Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Encompass Health
EHC
$12.2B
| $8.27M | 0.01% |
214,696
-678,025
| -76% | -$24.8M |
|
1402
Santander
BSBR
$42.8B
| $8.26M | 0.01% |
1,145,685
+935,571
| +445% | +$7.15M |
|
|
RNET
1403
DELISTED
RigNet, Inc.
RNET
| $8.24M | 0.01% |
513,700
+45,100
| +10% | +$820K |
|
1404
Core Molding Technologies
CMT
$227M
| $8.22M | 0.01% |
380,315
+45,915
| +14% | +$912K |
|
1405
Regional Management Corp
RM
$307M
| $8.21M | 0.01% |
347,400
-7,600
| -2% | -$160K |
|
1406
ACI Worldwide
ACIW
$5.38B
| $8.2M | 0.01% |
+366,633
| New | +$8.21M |
|
|
DISCK
1407
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $8.15M | 0.01% |
323,250
+204,400
| +172% | +$5.39M |
|
1408
Dime Commercial Bancshares
DCOM
$1.81B
| $8.13M | 0.01% |
244,132
+59,232
| +32% | +$2.03M |
|
|
CCC
1409
DELISTED
Calgon Carbon Corp
CCC
| $8.1M | 0.01% |
536,500
+12,600
| +2% | +$180K |
|
1410
Realty Income
O
$59.6B
| $8.06M | 0.01% |
150,775
-28,793
| -16% | -$1.59M |
|
1411
Clean Energy Fuels
CLNE
$403M
| $8.06M | 0.01% |
3,173,078
-549,200
| -15% | -$1.36M |
|
1412
STAG Industrial
STAG
$7.12B
| $8.05M | 0.01% |
291,800
+273,600
| +1,503% | +$7.32M |
|
1413
Super Micro Computer
SMCI
$25.6B
| $8.01M | 0.01% |
+3,251,000
| New | +$7.95M |
|
|
CLGX
1414
DELISTED
Corelogic, Inc.
CLGX
| $8M | 0.01% |
+184,486
| New | +$7.79M |
|
1415
Evolution Petroleum
EPM
$132M
| $7.99M | 0.01% |
986,800
+79,000
| +9% | +$616K |
|
|
HTBK
1416
DELISTED
Heritage Commerce
HTBK
| $7.98M | 0.01% |
579,100
-1,100
| -0.2% | -$15.2K |
|
1417
Vishay Precision Group
VPG
$953M
| $7.96M | 0.01% |
460,100
+8,300
| +2% | +$142K |
|
1418
Liberty Broadband Class A
LBRDA
$5.25B
| $7.95M | 0.01% |
92,700
-32,800
| -26% | -$2.83M |
|
|
HDP
1419
DELISTED
Hortonworks, Inc.
HDP
| $7.95M | 0.01% |
617,500
+533,700
| +637% | +$6.4M |
|
1420
Zillow
Z
$7.85B
| $7.93M | 0.01% |
+161,814
| New | +$6.78M |
|
1421
Bar Harbor Bankshares
BHB
$680M
| $7.93M | 0.01% |
257,296
-16,200
| -6% | -$488K |
|
1422
Phibro Animal Health
PAHC
$1.4B
| $7.92M | 0.01% |
213,784
+162,384
| +316% | +$5.3M |
|
|
XIN
1423
DELISTED
Xinyuan Real Estate
XIN
| $7.92M | 0.01% |
152,882
-10,338
| -6% | -$483K |
|
1424
Diageo
DEO
$53B
| $7.91M | 0.01% |
+66,000
| New | +$7.86M |
|
1425
Cedar Fair
FUN
$1.7B
| $7.9M | 0.01% |
109,550
-104,500
| -49% | -$7.35M |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.